China Meheco Group Co., Ltd. (600056.SS)

CNY 11.66

(-0.34%)

Market Cap (In CNY)

17.44 Billion

Revenue (In CNY)

38.82 Billion

Net Income (In CNY)

1.04 Billion

Avg. Volume

7.58 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
9.47-13.88
PE
-
EPS
-
Beta Value
0.136
ISIN
CNE000000Q29
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Distribution
CEO
Ms. Huidong Hu
Employee Count
-
Website
https://www.meheco.com
Ipo Date
1997-05-15
Details
China Meheco Group Co., Ltd. engages in the pharmaceutical business in China and internationally. The company imports and exports China national medicines and health products; produces and distributes pharmaceutical and health care products; and operates retail chain pharmacies. Its products include bulk pharmaceutical chemicals antibiotic fermentation and chemical synthesis tablets, injections, capsules, etc.; antibiotics; medicines for the treatment of cardio-cerebrovascular diseases, chronic diseases, and diabetes; antiviral drugs; anti-infectious agents; gastrointestinal drugs; non-steroidal anti-inflammatory drugs; anti-allergic agents; specialty botanicals; western medicine preparations; Chinese patent medicines and herbal pieces; medical equipment and supplies; biological products and raw materials; chemical raw materials; and nutritional and other healthcare products. The company also plants, processes, warehouses, and transports ginseng, licorice, ephedra, rhubarb, rheum officinale, astragalus membranaceus, scutellaria baicalensis, fennel, and other herbs. China Meheco Group Co., Ltd. was founded in 1984 and is based in Beijing, China.